SCR-LIP-000287 · Claim · machine-readable JSON →
In a case-control study, carriers of the IL-6 rs1800795 G allele had a 5.92-fold higher risk of lipedema (OR=5.92, 95%CI 1.983–17.711, p<0.001), and DXA-derived body composition indices (reduced WHR 0.73 vs 0.79, higher lower-limb FM% 48.90% vs 42.55%) combined with genetic analysis were proposed as tools for differential diagnosis between lipedema, normal-weight obesity, and obesity.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- The role of IL-6 gene polymorphisms in the risk of lipedema — Di Renzo L et al. (2020) ✓ verified — consistent · cross sectional · 2020 · reading confidence: moderate
The article proposes composite body-composition indices and IL-6 genotyping as promising tools for diagnosis and differential analysis of lipedema, indirectly supporting that screening/diagnostic tools can help identify it; however it does
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? consistent
- What specific genetic variants or inheritance patterns have been identified in lipedema? consistent
- Can screening tools or questionnaires help identify lipedema cases? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-06-02 — merged · absorbed duplicate SCR-LIP-000214
- 2026-05-31 — created · auto-ingested for SQ-LIP-000004